Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.5 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.5 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.5 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.16 | 0.5 |